• English
  • 简体中文
Login Register
Current Location: Home > Drug Registration and Acceptance subscription Help
-
-
-
Visualized Analysis Export Evaluation Conclusion Evaluation Progress
Acceptance No. Drug Name Active Ingredient Dosage Form Classification Submission Acceptance Date Manufacturers Manufacturers Review Status Status Date View
CYSB2400295 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(原10) Supplementary Application 2024-11-12 SinoCelltech Ltd view
CYSB2400294 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(原10) Supplementary Application 2024-11-12 SinoCelltech Ltd view
CXSB2400122 注射用重组人凝血因子Ⅷ-Fc融合蛋白 Recombinant Human Coagulation Factor VIII-Fc Fusion Protein Lyophilized Biological Products(2.4) Supplementary Application 2024-10-13 Chengdu Rongsheng Pharmaceuticals Co Ltd view
JYSB2400181 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-08-14 view
JYSB2400179 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-08-14 view
JYSB2400180 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-08-14 view
JYSB2400182 注射用重组人凝血因子VIII Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-08-14 view
CXSS2400077 人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.4) New Drug Application 2024-07-23 Bohui Biopharmaceutical (Hebei) Co Ltd view
JYSB2400155 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-07-16 view
JYSB2400156 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-07-16 view
JYSB2400157 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-07-16 view
JYSB2400158 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-07-16 view
CYSB2400160 人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-06-21 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CYSB2400133 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(原10) Supplementary Application 2024-05-24 SinoCelltech Ltd view
CYSB2400134 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(原10) Supplementary Application 2024-05-24 SinoCelltech Ltd view
CYSB2400123 人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.4) Supplementary Application 2024-05-17 Hualan Biological Engineering Chongqing Co Ltd view
CYSB2400124 人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.4) Supplementary Application 2024-05-17 Hualan Biological Engineering Chongqing Co Ltd view
CYSB2400087 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.4) Supplementary Application 2024-04-09 Chengdu Rongsheng Pharmaceuticals Co Ltd view
CXSL2400210 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products(3.4) New Drug Application 2024-04-03 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view
CXSB2400019 注射用重组人凝血因子Ⅷ Recombinant Coagulation Factor Ⅷ Lyophilized Biological Products Supplementary Application 2024-03-09 Nanjing Shunxin Pharmaceuticals Co LTDof Chiatai Tianqing Pharmaceutical Group view